EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer ...
The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer ...
Novartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on ...
Novartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival ...
GlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing countries, helping to protect millions ...
Published in the European Journal of Heart Failure1, results from a new sub-analysis of the RE-LY®* trial demonstrate important benefits ...
New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented ...
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute ...
AstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive ...
Bristol-Myers Squibb Company and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted and granted a Priority ...
An ambitious new partnership to save the lives of a million of the poorest children in the world has been ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.